Bausch Health Companies (BHC) Stock Forecast & Price Target

$8.20 +0.01 (+0.12%)

(As of 11/20/2024 ET)

Bausch Health Companies - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 7 Analyst Ratings

Sell
1

Hold
5

Buy
1

Based on 7 Wall Street analysts who have issued ratings for Bausch Health Companies in the last 12 months, the stock has a consensus rating of "Hold." Out of the 7 analysts, 1 has given a sell rating, 5 have given a hold rating, and 1 has given a buy rating for BHC.

Consensus Price Target

$7.75
-5.43% Downside

According to the 7 analysts' twelve-month price targets for Bausch Health Companies, the average price target is $7.75. The highest price target for BHC is $11.00, while the lowest price target for BHC is $3.00. The average price target represents a forecasted downside of -5.43% from the current price of $8.20.

Get the Latest News and Ratings for BHC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Bausch Health Companies and its competitors.

BHC Analyst Ratings Over Time

Type	Current Forecast 11/22/23 to 11/21/24	1 Month Ago 10/23/23 to 10/22/24	3 Months Ago 8/24/23 to 8/23/24	1 Year Ago 11/22/22 to 11/22/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)
Hold	5 Hold rating(s)	5 Hold rating(s)	4 Hold rating(s)	2 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$7.75	$7.33	$7.33	$12.50
Forecasted Upside	-5.43% Downside	-9.52% Downside	25.04% Upside	81.95% Upside
Consensus Rating	Hold	Hold	Hold	Hold

When it comes to NVDA… “acceleration cycles” are the key (Ad)

Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.

Use this link to see Nvidia Unchained right away!

BHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

BHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Bausch Health Companies Stock vs. The Competition

Type	Bausch Health Companies	Medical Companies	S&P 500
Consensus Rating Score	2.00	2.80	2.50
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	-5.43% Downside	26,931.56% Upside	9.82% Upside
News Sentiment Rating	Positive News See Recent BHC News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/1/2024	Royal Bank of Canada 4 of 5 stars		Boost Target	Sector Perform ➝ Sector Perform	$10.00 ➝ $11.00	+15.79%
10/15/2024	Evercore ISI 2 of 5 stars	U. Raffat Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
8/7/2024	Jefferies Financial Group 2 of 5 stars		Lower Target	Buy	$13.00 ➝ $9.00	+70.78%
8/2/2024	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Sector Perform	$10.00 ➝ $8.50	+47.57%
8/2/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Neutral ➝ Underweight	$9.00 ➝ $3.00	-50.82%
7/25/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Hold ➝ Hold	$8.00 ➝ $7.00	+18.85%
7/10/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Nachman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Market Perform	$8.00	+11.19%
6/16/2023	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 06:27 AM ET.

BHC Forecast - Frequently Asked Questions

: According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Bausch Health Companies is $7.75, with a high forecast of $11.00 and a low forecast of $3.00.
: 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bausch Health Companies in the last twelve months. There is currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" BHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BHC, but not buy additional shares or sell existing shares.
: According to analysts, Bausch Health Companies's stock has a predicted downside of -5.43% based on their 12-month stock forecasts.
: Over the previous 90 days, Bausch Health Companies's stock had 1 upgrade by analysts.
: Bausch Health Companies has been rated by research analysts at Evercore ISI, and Royal Bank of Canada in the past 90 days.
: Analysts like Bausch Health Companies less than other "medical" companies. The consensus rating for Bausch Health Companies is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how BHC compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

When it comes to NVDA… “acceleration cycles” are the key (Ad)

Use this link to see Nvidia Unchained right away!

This page (NYSE:BHC) was last updated on 11/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bausch Health Companies (BHC) Stock Forecast & Price Target